Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Jan, 2015 | Pages:
714 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
Head And Neck Cancer - Pipeline Review, H1 2015 Summary Global Markets Direct's, 'Head And Neck Cancer - Pipeline Review, H1 2015', provides an overview of the Head And Neck Cancer's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Head And Neck Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Head And Neck Cancer and special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides a snapshot of the global therapeutic landscape of Head And Neck Cancer - The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved in the therapeutics development for Head And Neck Cancer and enlists all their major and minor projects - The report summarizes all the dormant and discontinued pipeline projects - A review of the Head And Neck Cancer products under development by companies and universities/research institutes based on information derived from company and industry-specific sources - Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages - A detailed assessment of monotherapy and combination therapy pipeline projects - Coverage of the Head And Neck Cancer pipeline on the basis of target, MoA, route of administration and molecule type - Latest news and deals relating related to pipeline products Reasons To Buy - Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop strategic initiatives by understanding the focus areas of leading companies - Identify and understand important and diverse types of therapeutics under development for Head And Neck Cancer - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Devise corrective measures for pipeline projects by understanding Head And Neck Cancer pipeline depth and focus of Indication therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
Table of Contents Table of Contents 2 Introduction 8 Head And Neck Cancer Overview 9 Therapeutics Development 10 Head And Neck Cancer - Therapeutics under Development by Companies 12 Head And Neck Cancer - Therapeutics under Investigation by Universities/Institutes 22 Head And Neck Cancer - Pipeline Products Glance 25 Head And Neck Cancer - Products under Development by Companies 29 Head And Neck Cancer - Products under Investigation by Universities/Institutes 41 Head And Neck Cancer - Companies Involved in Therapeutics Development 44 Head And Neck Cancer - Therapeutics Assessment 156 Drug Profiles 180 Head And Neck Cancer - Recent Pipeline Updates 513 Head And Neck Cancer - Dormant Projects 673 Head And Neck Cancer - Discontinued Products 683 Head And Neck Cancer - Product Development Milestones 684 Appendix 692
List of Tables Number of Products under Development for Head And Neck Cancer, H1 2015 31 Number of Products under Development for Head And Neck Cancer - Comparative Analysis, H1 2015 32 Number of Products under Development by Companies, H1 2015 34 Number of Products under Development by Companies, H1 2015 (Contd..1) 35 Number of Products under Development by Companies, H1 2015 (Contd..2) 36 Number of Products under Development by Companies, H1 2015 (Contd..3) 37 Number of Products under Development by Companies, H1 2015 (Contd..4) 38 Number of Products under Development by Companies, H1 2015 (Contd..5) 39 Number of Products under Development by Companies, H1 2015 (Contd..6) 40 Number of Products under Development by Companies, H1 2015 (Contd..7) 41 Number of Products under Development by Companies, H1 2015 (Contd..8) 42 Number of Products under Investigation by Universities/Institutes, H1 2015 44 Number of Products under Investigation by Universities/Institutes, H1 2015 (Contd..1) 45 Comparative Analysis by Late Stage Development, H1 2015 46 Comparative Analysis by Clinical Stage Development, H1 2015 47 Comparative Analysis by Early Stage Development, H1 2015 48 Comparative Analysis by Unknown Stage Development, H1 2015 49 Products under Development by Companies, H1 2015 50 Products under Development by Companies, H1 2015 (Contd..1) 51 Products under Development by Companies, H1 2015 (Contd..2) 52 Products under Development by Companies, H1 2015 (Contd..3) 53 Products under Development by Companies, H1 2015 (Contd..4) 54 Products under Development by Companies, H1 2015 (Contd..5) 55 Products under Development by Companies, H1 2015 (Contd..6) 56 Products under Development by Companies, H1 2015 (Contd..7) 57 Products under Development by Companies, H1 2015 (Contd..8) 58 Products under Development by Companies, H1 2015 (Contd..9) 59 Products under Development by Companies, H1 2015 (Contd..10) 60 Products under Development by Companies, H1 2015 (Contd..11) 61 Products under Investigation by Universities/Institutes, H1 2015 62 Products under Investigation by Universities/Institutes, H1 2015 (Contd..1) 63 Products under Investigation by Universities/Institutes, H1 2015 (Contd..2) 64 Head And Neck Cancer - Pipeline by 3M Drug Delivery Systems, H1 2015 65 Head And Neck Cancer - Pipeline by AB Science, H1 2015 66 Head And Neck Cancer - Pipeline by Acceleron Pharma, Inc., H1 2015 67 Head And Neck Cancer - Pipeline by Advaxis, Inc., H1 2015 68 Head And Neck Cancer - Pipeline by Ambrx, Inc., H1 2015 69 Head And Neck Cancer - Pipeline by Amgen Inc., H1 2015 70 Head And Neck Cancer - Pipeline by arGEN-X BV, H1 2015 71 Head And Neck Cancer - Pipeline by ArQule, Inc., H1 2015 72 Head And Neck Cancer - Pipeline by Ascenta Therapeutics, Inc., H1 2015 73 Head And Neck Cancer - Pipeline by Astellas Pharma Inc., H1 2015 74 Head And Neck Cancer - Pipeline by AstraZeneca PLC, H1 2015 75 Head And Neck Cancer - Pipeline by AVEO Pharmaceuticals, Inc., H1 2015 76 Head And Neck Cancer - Pipeline by Bayer AG, H1 2015 77 Head And Neck Cancer - Pipeline by Bexion Pharmaceuticals, LLC., H1 2015 78 Head And Neck Cancer - Pipeline by Bio-Path Holdings, Inc., H1 2015 79 Head And Neck Cancer - Pipeline by BioDiem Ltd, H1 2015 80 Head And Neck Cancer - Pipeline by Bionomics Limited, H1 2015 81 Head And Neck Cancer - Pipeline by Biotest AG, H1 2015 82 Head And Neck Cancer - Pipeline by Boehringer Ingelheim GmbH, H1 2015 83 Head And Neck Cancer - Pipeline by Boston Biomedical, Inc., H1 2015 84 Head And Neck Cancer - Pipeline by Bristol-Myers Squibb Company, H1 2015 85 Head And Neck Cancer - Pipeline by CEL-SCI Corporation, H1 2015 86 Head And Neck Cancer - Pipeline by Celgene Corporation, H1 2015 87 Head And Neck Cancer - Pipeline by Cellceutix Corporation, H1 2015 88 Head And Neck Cancer - Pipeline by Celldex Therapeutics, Inc., H1 2015 89 Head And Neck Cancer - Pipeline by Celltrion, Inc., H1 2015 90 Head And Neck Cancer - Pipeline by Centrose Llc, H1 2015 91 Head And Neck Cancer - Pipeline by CTI BioPharma Corp., H1 2015 92 Head And Neck Cancer - Pipeline by Cyclacel Pharmaceuticals, Inc., H1 2015 93 Head And Neck Cancer - Pipeline by CytomX Therapeutics, Inc., H1 2015 94 Head And Neck Cancer - Pipeline by Daewoong Pharmaceutical Co., Ltd., H1 2015 95 Head And Neck Cancer - Pipeline by Daiichi Sankyo Company, Limited, H1 2015 96 Head And Neck Cancer - Pipeline by EcoBiotics Limited, H1 2015 97 Head And Neck Cancer - Pipeline by Eisai Co., Ltd., H1 2015 98 Head And Neck Cancer - Pipeline by Eli Lilly and Company, H1 2015 99 Head And Neck Cancer - Pipeline by EntreChem, S.L., H1 2015 100 Head And Neck Cancer - Pipeline by Etubics Corporation, H1 2015 101 Head And Neck Cancer - Pipeline by F. Hoffmann-La Roche Ltd., H1 2015 102 Head And Neck Cancer - Pipeline by Genelux Corporation, H1 2015 103 Head And Neck Cancer - Pipeline by Genentech, Inc., H1 2015 104 Head And Neck Cancer - Pipeline by Genexine, Inc., H1 2015 105 Head And Neck Cancer - Pipeline by Genmab A/S, H1 2015 106 Head And Neck Cancer - Pipeline by GlaxoSmithKline plc, H1 2015 107 Head And Neck Cancer - Pipeline by Gliknik, Inc., H1 2015 108 Head And Neck Cancer - Pipeline by Glycotope GmbH, H1 2015 109 Head And Neck Cancer - Pipeline by Green Cross Corporation, H1 2015 110 Head And Neck Cancer - Pipeline by ImmunoGen, Inc., H1 2015 111 Head And Neck Cancer - Pipeline by Immunomedics, Inc., H1 2015 112 Head And Neck Cancer - Pipeline by Immunovative Therapies, Ltd., H1 2015 113 Head And Neck Cancer - Pipeline by Incuron, LLC, H1 2015 114 Head And Neck Cancer - Pipeline by Incyte Corporation, H1 2015 115 Head And Neck Cancer - Pipeline by Innate Pharma SA, H1 2015 116 Head And Neck Cancer - Pipeline by Inovio Pharmaceuticals, Inc., H1 2015 117 Head And Neck Cancer - Pipeline by InteRNA Technologies B.V., H1 2015 118 Head And Neck Cancer - Pipeline by ISU ABXIS Co.,Ltd., H1 2015 119 Head And Neck Cancer - Pipeline by Jiangsu Kanion Pharmaceutical Co., Ltd., H1 2015 120 Head And Neck Cancer - Pipeline by Karyopharm Therapeutics, Inc., H1 2015 121 Head And Neck Cancer - Pipeline by Laboratoires Pierre Fabre SA, H1 2015 122 Head And Neck Cancer - Pipeline by Lytix Biopharma AS, H1 2015 123 Head And Neck Cancer - Pipeline by Mabion SA, H1 2015 124 Head And Neck Cancer - Pipeline by MacroGenics, Inc., H1 2015 125 Head And Neck Cancer - Pipeline by Marsala Biotech Inc., H1 2015 126 Head And Neck Cancer - Pipeline by MedImmune, LLC, H1 2015 127 Head And Neck Cancer - Pipeline by Merck & Co., Inc., H1 2015 128 Head And Neck Cancer - Pipeline by Merck KGaA, H1 2015 129 Head And Neck Cancer - Pipeline by Merrimack Pharmaceuticals, Inc., H1 2015 130 Head And Neck Cancer - Pipeline by Mirati Therapeutics Inc., H1 2015 131 Head And Neck Cancer - Pipeline by Mission Therapeutics Ltd, H1 2015 132 Head And Neck Cancer - Pipeline by Molplex Ltd., H1 2015 133 Head And Neck Cancer - Pipeline by Multimmune GmbH, H1 2015 134 Head And Neck Cancer - Pipeline by Nanobiotix, H1 2015 135 Head And Neck Cancer - Pipeline by Natco Pharma Limited, H1 2015 136 Head And Neck Cancer - Pipeline by Novartis AG, H1 2015 137 Head And Neck Cancer - Pipeline by Omnitura Therapeutics Inc., H1 2015 138 Head And Neck Cancer - Pipeline by Oncobiologics, Inc., H1 2015 139 Head And Neck Cancer - Pipeline by Oncolys BioPharma Inc., H1 2015 140 Head And Neck Cancer - Pipeline by Oncolytics Biotech Inc., H1 2015 141 Head And Neck Cancer - Pipeline by Onconova Therapeutics, Inc., H1 2015 142 Head And Neck Cancer - Pipeline by OncoSec Medical Inc., H1 2015 143 Head And Neck Cancer - Pipeline by Oncovir, Inc., H1 2015 144 Head And Neck Cancer - Pipeline by Ono Pharmaceutical Co., Ltd., H1 2015 145 Head And Neck Cancer - Pipeline by Otsuka Holdings Co., Ltd., H1 2015 146 Head And Neck Cancer - Pipeline by OXiGENE, Inc., H1 2015 147 Head And Neck Cancer - Pipeline by Panacea Biotec Limited, H1 2015 148 Head And Neck Cancer - Pipeline by PCI Biotech AS, H1 2015 149 Head And Neck Cancer - Pipeline by Pfizer Inc., H1 2015 150 Head And Neck Cancer - Pipeline by Pharmacyclics, Inc., H1 2015 151 Head And Neck Cancer - Pipeline by Pique Therapeutics, H1 2015 152 Head And Neck Cancer - Pipeline by Piramal Enterprises Limited, H1 2015 153 Head And Neck Cancer - Pipeline by PlantForm Corporation, H1 2015 154 Head And Neck Cancer - Pipeline by PNP Therapeutics, Inc., H1 2015 155 Head And Neck Cancer - Pipeline by Profectus BioSciences, Inc., H1 2015 156 Head And Neck Cancer - Pipeline by Sareum Holdings plc, H1 2015 157 Head And Neck Cancer - Pipeline by Selecta Biosciences, Inc., H1 2015 158 Head And Neck Cancer - Pipeline by SentoClone International AB, H1 2015 159 Head And Neck Cancer - Pipeline by Serina Therapeutics, Inc., H1 2015 160 Head And Neck Cancer - Pipeline by Shionogi & Co., Ltd., H1 2015 161 Head And Neck Cancer - Pipeline by Silence Therapeutics plc, H1 2015 162 Head And Neck Cancer - Pipeline by SillaJen Co. Ltd., H1 2015 163 Head And Neck Cancer - Pipeline by Synta Pharmaceuticals Corp., H1 2015 164 Head And Neck Cancer - Pipeline by Takara Bio Inc., H1 2015 165 Head And Neck Cancer - Pipeline by Teva Pharmaceutical Industries Limited, H1 2015 166 Head And Neck Cancer - Pipeline by Theravectys S.A., H1 2015 167 Head And Neck Cancer - Pipeline by Transgene SA, H1 2015 168 Head And Neck Cancer - Pipeline by VasGene Therapeutics, Inc., H1 2015 169 Head And Neck Cancer - Pipeline by VentiRx Pharmaceuticals, Inc., H1 2015 170 Head And Neck Cancer - Pipeline by Virttu Biologics Limited, H1 2015 171 Head And Neck Cancer - Pipeline by Viventia Biotechnologies Inc., H1 2015 172 Head And Neck Cancer - Pipeline by VLPbio, H1 2015 173 Head And Neck Cancer - Pipeline by VM Discovery, Inc., H1 2015 174 Head And Neck Cancer - Pipeline by Zhejiang BetaPharma Co., Ltd., H1 2015 175 Head And Neck Cancer - Pipeline by Zyngenia, Inc., H1 2015 176 Assessment by Monotherapy Products, H1 2015 177 Assessment by Combination Products, H1 2015 178 Number of Products by Stage and Target, H1 2015 180 Number of Products by Stage and Mechanism of Action, H1 2015 190 Number of Products by Stage and Route of Administration, H1 2015 198 Number of Products by Stage and Molecule Type, H1 2015 200 Head And Neck Cancer Therapeutics - Recent Pipeline Updates, H1 2015 534 Head And Neck Cancer - Dormant Projects, H1 2015 694 Head And Neck Cancer - Dormant Projects (Contd..1), H1 2015 695 Head And Neck Cancer - Dormant Projects (Contd..2), H1 2015 696 Head And Neck Cancer - Dormant Projects (Contd..3), H1 2015 697 Head And Neck Cancer - Dormant Projects (Contd..4), H1 2015 698 Head And Neck Cancer - Dormant Projects (Contd..5), H1 2015 699 Head And Neck Cancer - Dormant Projects (Contd..6), H1 2015 700 Head And Neck Cancer - Dormant Projects (Contd..7), H1 2015 701 Head And Neck Cancer - Dormant Projects (Contd..8), H1 2015 702 Head And Neck Cancer - Dormant Projects (Contd..9), H1 2015 703 Head And Neck Cancer - Discontinued Products, H1 2015 704
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
